Scolaris Content Display Scolaris Content Display

Antibiotic prophylaxis for the prevention of Methicillin resistant Staphylococcus aureus (MRSA) infections and related complications in surgical patients

This is not the most recent version

References

Additional references

Barber 1961

Barber M. Methicillin‐resistant staphylococci. Journal of Clinical Pathology 1961;14:385‐93.

Boyce 1994

Boyce JM, Jackson MM, Pugliese G, Batt MD, Fleming D, Garner JS, et al. Methicillin‐resistant Staphylococcus aureus (MRSA): a briefing for acute care hospitals and nursing facilities. Infection Control and Hospital Epidemiology 1994;15(2):105‐15.

Chambers 2010

Chambers D, Worthy G, Myers L, Weatherly H, Elliott R, Hawkins N, et al. Glycopeptide vs. non‐glycopeptide antibiotics for prophylaxis of surgical site infections: A systematic review. Surgical infections 2010;11(5):455‐62.

Chemaly 2010

Chemaly RF, Hachem RY, Husni RN, Bahna B, Rjaili GA, Waked A, et al. Characteristics and outcomes of methicillin‐resistant staphylococcus aureus surgical‐site infections in patients with cancer: A case‐control study. Annals of Surgical Oncology 2010;17(6):1499‐506.

Cowie 2005

Cowie SE, Ma I, Lee SK, Smith RM, Hsiang YN. Nosocomial MRSA infection in vascular surgery patients: Impact on patient outcome. Vascular and Endovascular Surgery 2005;39(4):327‐34.

Creamer 2011

Creamer E, Galvin S, Dolan A, Sherlock O, Dimitrov BD, Fitzgerald‐Hughes D, et al. Evaluation of screening risk and non risk patients for methicillin‐resistant Staphylococcus aureus on admission in an acute care hospital. American Journal of Infection Control 2011;Sep 30:epub ahead of print.

DeMets 1987

DeMets DL. Methods for combining randomized clinical trials: strengths and limitations. Statistics in Medicine 1987;6(3):341‐50.

DerSimonian 1986

DerSimonian R, Laird N. Meta‐analysis in clinical trials. Controlled Clinical Trials 1986;7(3):177‐88.

ECDC 2009a

ECDC. European centre for disease prevention and control. Annual epidemiological report on communicable diseases in Europe. http://www.ecdc.europa.eu/en/publications/Publications/0910_SUR_Annual_Epidemiological_Report_on_Communicable_Diseases_in_Europe.pdf 2009 (accessed on 17/07/2011).

ECDC 2009b

ECDC. European centre for disease prevention and control. The bacterial challenge: Time to react. A call to narrow the gap between multi‐drug resistant bacteria in the EU and the development of new anti‐bacterial agents. http://www.ecdc.europa.eu/en/publications/Publications/0909_TER_The_Bacterial_Challenge_Time_to_React.pdf 2009 (accessed on 17/07/2011).

Egger 1997

Egger M, Davey SG, Schneider M, Minder C. Bias in meta‐analysis detected by a simple, graphical test. BMJ 1997;315(7109):629‐34.

Fraser 2010

Fraser S, Brady R, Graham C, Paterson‐Brown S, Gibb A. Methicillin‐resistant staphylococcus aureus in surgical patients: Identification of high‐risk populations for the development of targeted screening programmes. Annals of the Royal College of Surgeons of England 2010;92(4):311‐5.

Gurusamy 2009

Gurusamy KS, Gluud C, Nikolova D, Davidson BR. Assessment of risk of bias in randomized clinical trials in surgery. British Journal of Surgery 2009;96(4):342‐9.

Gurusamy 2012

Gurusamy K, Wilson P, Davidson BR. Antibiotic therapy for the treatment of surgical site infections (SSI) due to Methicillin resistant Staphylococcus aureus (MRSA). Cochrane Database of Systematic Reviews Under preparation.

Harbarth 2008a

Harbarth S, Huttner B, Gervaz P, Fankhauser C, Chraiti MN, Schrenzel J, et al. Risk factors for methicillin‐resistant staphylococcus aureus surgical site infection. Infection Control and Hospital Epidemiology 2008;29(9):890‐3.

Harbarth 2008b

Harbarth S, Fankhauser C, Schrenzel J, Christenson J, Gervaz P, Bandiera‐Clerc C, et al. Universal screening for methicillin‐resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA 2008;299(10):1149‐57.

Higgins 2002

Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta‐analysis. Statistics in Medicine 2002;21(11):1539‐58.

Higgins 2011a

Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Colloboration, 2011. Available from www.cochrane‐handbook.org.

Higgins 2011b

Higgins JPT, Altman DG, on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group (Editors). Chapter 8:  Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Higgins 2011c

Higgins JPT, Deeks JJ and Altman DG on behalf of the Cochrane Statistical Methods Group (Editors). Chapter 16: Special topics in statistics. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Horan 1992

Horan TC, Gaynes RP, Martone WJ, Jarvis WR, Emori TG. CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections. Infection Control and Hospital Epidemiology 1992;13(10):606‐8.

ICH‐GCP 1996

International Conference on Harmonisation of Technical Requiements for Registration of Pharmaceuticals for Human Use. Code of Federal Regulation & ICH Guidelines. Media: Parexel Barnett, 1996.

Jevons 1961

Jevons PM. “Celbenin” ‐ resistant Staphylococci. British Medical Journal 1961;1(5219):124‐5.

Kallen 2010

Kallen AJ, Mu Y, Bulens S, Reingold A, Petit S, Gershman K, et al. Health care‐associated invasive MRSA infections, 2005‐2008. JAMA 2010;304(6):641‐8.

Kang 2012

Kang J, Mandsager P, Biddle AK, Weber DJ. Cost‐Effectiveness Analysis of Active Surveillance Screening for Methicillin‐Resistant Staphylococcus aureus in an Academic Hospital Setting. Infection Control and Hospital Epidemiology 2012;33(5):477‐86.

Kaye 2008

Kaye KS, Anderson DJ, Choi Y, Link K, Thacker P, Sexton DJ. The deadly toll of invasive methicillin‐resistant staphylococcus aureus infection in community hospitals. Clinical Infectious Diseases 2008;46(10):1568‐77.

Kjaergard 2001

Kjaergard LL, Villumsen J, Gluud C. Reported methodologic quality and discrepancies between large and small randomized trials in meta‐analyses. Annals of Internal Medicine 2001;135(11):982‐9.

Klimek 1976

Klimek JJ, Marsik FJ, Bartlett RC, Weir B, Shea P, Quintiliani R. Clinical, epidemiologic and bacteriologic observations of an outbreak of methicillin‐resistant staphylococcus aureus at a large community hospital. American Journal of Medicine 1976;61(3):340‐5.

Knox 1961

Knox R, Smith JT. The nature of penicillin resistance in staphylococci. Lancet 1961;2(7201):520‐2.

Kuehnert 2005

Kuehnert MJ, Hill HA, Kupronis BA, Tokars JI, Solomon SL, Jernigan DB. Methicillin‐resistant–staphylococcus aureus hospitalizations, United States. Emerging Infectious Diseases 2005;11(6):868‐72.

Lamagni 2011

Lamagni TL, Potz N, Powell D, Pebody R, Wilson J, Duckworth G. Mortality in patients with meticillin‐resistant staphylococcus aureus bacteraemia, England 2004‐2005. Journal of Hospital Infection 2011;77(1):16‐20.

Lefebvre 2011

Lefebvre C, Manheimer E, Glanville J on behalf of the Cochrane Information Retrieval Methods Group. Chapter 6:  Searching for studies.. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Lewis 2011

Lewis T, Chaudhry R, Nightingale P, Lambert P, Das I. Methicillin‐resistant staphylococcus aureus bacteremia: Epidemiology, outcome, and laboratory characteristics in a tertiary referral center in the UK. International Journal of Infectious Diseases 2011;15(2):e131‐5.

Liu 2011

Liu C, Bayer A, Cosgrove SE, Daum RS, Fridkin SK, Gorwitz RJ, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin‐resistant Staphylococcus aureus infections in adults and children: executive summary. Clinical Infectious Diseases 2011;52(3):285‐92.

Loeb 2003

Loeb MB, Main C, Eady A, Walkers‐Dilks C. Antimicrobial drugs for treating methicillin‐resistant staphylococcus aureus colonization. Cochrane Database of Systematic Reviews 2003, Issue 4. [DOI: 10.1002/14651858.CD003340]

Macaskill 2001

Macaskill P, Walter SD, Irwig L. A comparison of methods to detect publication bias in meta‐analysis. Statistics in Medicine 2001;20(4):641‐54.

Moher 1998

Moher D, Pham B, Jones A, Cook DJ, Jadad AR, Moher M, et al. Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta‐analyses?. Lancet 1998;352(9128):609‐13.

Muto 2003

Muto CA, Jernigan JA, Ostrowsky BE, Richet HM, Jarvis WR, Boyce JM, et al. SHEA guideline for preventing nosocomial transmission of multidrug‐resistant strains of Staphylococcus aureus and enterococcus. Infection Control and Hospital Epidemiology 2003;24(5):362‐86.

Newell 1992

Newell DJ. Intention‐to‐treat analysis: implications for quantitative and qualitative research. International Journal of Epidemiology 1992;21(5):837‐41.

O'Toole 1970

O'Toole RD, Drew WL, Dahlgren BJ, Beaty HN. An outbreak of methicillin‐resistant staphylococcus aureus infection. Observations in hospital and nursing home. JAMA 1970;213(2):257‐63.

OED 2011

OED. Oxford English dictionary. The definitive record of the English language. http://www.oed.com/ 2011 (accessed on 7th April, 2011).

Otter 2011

Otter JA, French GL. Community‐associated meticillin‐resistant staphylococcus aureus strains as a cause of healthcare‐associated infection. Journal of Hospital Infection 2011;79(3):189‐93.

Parmar 1998

Parmar MK, Torri V, Stewart L. Extracting summary statistics to perform meta‐analyses of the published literature for survival endpoints. Statistics in Medicine 1998;17(24):2815‐34.

Reddy 2007

Reddy SL, Grayson AD, Smith G, Warwick R, Chalmers JA. Methicillin resistant staphylococcus aureus infections following cardiac surgery: Incidence, impact and identifying adverse outcome traits. European Journal of Cardio‐Thoracic Surgery 2007;32(1):113‐7.

RevMan 2011 [Computer program]

Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.1. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2011.

Ridgeway 2005

Ridgeway S, Wilson J, Charlet A, Kafatos G, Pearson A, Coello R. Infection of the surgical site after arthroplasty of the hip. Journal of Bone and Joint Surgery. British Volume 2005;87(6):844‐50.

Saginur 2000

Saginur R, Croteau D, Bergeron MG. Comparative efficacy of teicoplanin and cefazolin for cardiac operation prophylaxis in 3027 patients. The ESPRIT Group. Journal of Thoracic and Cardiovascular Surgery 2000;120(6):1120‐30.

Sanjay 2010

Sanjay P, Fawzi A, Kulli C, Polignano FM, Tait IS. Impact of methicillin‐resistant Staphylococcus aureus (MRSA) infection on patient outcome after pancreatoduodenectomy (PD)‐‐a cause for concern?. Pancreas 2010;39(8):1211‐4.

Schulz 1995

Schulz KF, Chalmers I, Hayes RJ, Altman DG. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273(5):408‐12.

Schunemann 2011a

Schünemann HJ, Oxman AD, Higgins JPT, Vist GE, Glasziou P, Guyatt GH. Chapter 11: Presenting results and ‘Summary of findings' tables. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org.

Schunemann 2011b

Schünemann HJ, Oxman AD, Vist GE, Higgins JPT, Deeks JJ, Glasziou P, Guyatt GH. Chapter 12: Interpreting results and drawing conclusions. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org, 2011.

Shukla 2009

Shukla S, Nixon M, Acharya M, Korim MT, Pandey R. Incidence of MRSA surgical‐site infection in MRSA carriers in an orthopaedic trauma unit. Journal of Bone and Joint Surgery. British Volume 2009;91(2):225‐8.

SIGN 2011

Scottish Intercollegiate Guidelines Network (SIGN). Search filters. http://www.sign.ac.uk/methodology/filters.html#random2011.

Skov 2005

Skov R, SSAC MRSAWP. MRSA infections increasing in the Nordic countries. Euro Surveillance 2005;10(31):E050804.2.

Spence 2011

Spence MR, Dammel T, Courser S. Contact Precautions for methicillin‐resistant Staphylococcus aureus colonization: Costly and unnecessary?. American Journal of Infection Control 2011;19 October:epub ahead of print.

Tierney 2007

Tierney JF, Stewart LA, Ghersi D, Burdett S, Sydes MR. Practical methods for incorporating summary time‐to‐event data into meta‐analysis. Trials 2007;8:16.

Wang 2010

Wang JT, Wang JL, Fang CT, Chie WC, Lai MS, Lauderdale TL, et al. Risk factors for mortality of nosocomial methicillin‐resistant Staphylococcus aureus (MRSA) bloodstream infection: with investigation of the potential role of community‐associated MRSA strains. Journal of Infection 2010;61(6):449‐57.

Wood 2008

Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman GD, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta‐epidemiological study. BMJ 2008;336(7544):601‐5.

Wulf 2008

Wulf M, Voss A. MRSA in livestock animals‐an epidemic waiting to happen?. Clinical Microbiology and Infection 2008;14(6):519‐21.